The m7G modification: An emerging player in neurological diseases

Area of Science:

• RNA epigenetics
• Molecular biology
• Neuroscience

Background:

• 7-methylguanosine (m7G) is a key RNA post-transcriptional modification found in various RNA types.
• m7G influences RNA stability, nucleoplasmic transfer, and translation efficiency.
• In the CNS, m7G is regulated by METTL1/WDR4, RNMT/RAM, and WBSCR22/TRMT112 complexes.

Purpose of the Study:

• To review current knowledge on m7G modification in the CNS.
• To highlight recent findings on m7G distribution, regulation, detection, and prediction.
• To identify knowledge gaps and discuss translational opportunities in neurological medicine.

Main Methods:

• Literature review of m7G modification in RNA epigenetics and CNS.
• Analysis of regulatory factors, detection techniques, and prediction methods for m7G.
• Discussion of dysregulation in neurological diseases like Alzheimer's, ALS, and stroke.

Main Results:

• m7G dysregulation is associated with Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
• Key knowledge gaps include understanding m7G "readers" and "erasers," and cell-type-specific profiling in the brain.
• Translational opportunities involve biomarker discovery and therapeutic targeting of m7G regulators.

Conclusions:

• m7G modification plays a significant role in CNS function and neurological disease pathogenesis.
• Addressing knowledge gaps in m7G "readers," "erasers," and brain-specific functions is critical.
• Targeting m7G regulators offers potential for precision neurological medicine, but specificity challenges remain.